Literature DB >> 22089381

Is the virulence of HIV changing? A meta-analysis of trends in prognostic markers of HIV disease progression and transmission.

Joshua T Herbeck1, Viktor Müller, Brandon S Maust, Bruno Ledergerber, Carlo Torti, Simona Di Giambenedetto, Luuk Gras, Huldrych F Günthard, Lisa P Jacobson, James I Mullins, Geoffrey S Gottlieb.   

Abstract

OBJECTIVE: The potential for changing HIV-1 virulence has significant implications for the AIDS epidemic, including changing HIV transmission rates, rapidity of disease progression, and timing of ART. Published data to date have provided conflicting results.
DESIGN: We conducted a meta-analysis of changes in baseline CD4(+) T-cell counts and set point plasma viral RNA load over time in order to establish whether summary trends are consistent with changing HIV-1 virulence.
METHODS: We searched PubMed for studies of trends in HIV-1 prognostic markers of disease progression and supplemented findings with publications referenced in epidemiological or virulence studies. We identified 12 studies of trends in baseline CD4(+) T-cell counts (21, 052 total individuals), and eight studies of trends in set point viral loads (10 ,785 total individuals), spanning the years 1984-2010. Using random-effects meta-analysis, we estimated summary effect sizes for trends in HIV-1 plasma viral loads and CD4(+) T-cell counts.
RESULTS: Baseline CD4(+) T-cell counts showed a summary trend of decreasing cell counts [effect = -4.93  cells/μl per year, 95% confidence interval (CI) -6.53 to -3.3]. Set point viral loads showed a summary trend of increasing plasma viral RNA loads (effect = 0.013  log(10)  copies/ml per year, 95% CI -0.001 to 0.03). The trend rates decelerated in recent years for both prognostic markers.
CONCLUSION: Our results are consistent with increased virulence of HIV-1 over the course of the epidemic. Extrapolating over the 30 years since the first description of AIDS, this represents a CD4(+) T cells loss of approximately 148  cells/μl and a gain of 0.39  log(10)  copies/ml of viral RNA measured during early infection. These effect sizes would predict increasing rates of disease progression, and need for ART as well as increasing transmission risk.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22089381      PMCID: PMC3597098          DOI: 10.1097/QAD.0b013e32834db418

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


  70 in total

1.  Time from HIV-1 seroconversion to AIDS and death before widespread use of highly-active antiretroviral therapy: a collaborative re-analysis. Collaborative Group on AIDS Incubation and HIV Survival including the CASCADE EU Concerted Action. Concerted Action on SeroConversion to AIDS and Death in Europe.

Authors: 
Journal:  Lancet       Date:  2000-04-01       Impact factor: 79.321

2.  Adaptation of HIV-1 envelope gp120 to humoral immunity at a population level.

Authors:  Evelien M Bunnik; Zelda Euler; Matthijs R A Welkers; Brigitte D M Boeser-Nunnink; Marlous L Grijsen; Jan M Prins; Hanneke Schuitemaker
Journal:  Nat Med       Date:  2010-08-29       Impact factor: 53.440

3.  Viral load and heterosexual transmission of human immunodeficiency virus type 1. Rakai Project Study Group.

Authors:  T C Quinn; M J Wawer; N Sewankambo; D Serwadda; C Li; F Wabwire-Mangen; M O Meehan; T Lutalo; R H Gray
Journal:  N Engl J Med       Date:  2000-03-30       Impact factor: 91.245

4.  Are HIV-positive persons progressing faster after diagnosis over the epidemic?

Authors:  Nancy F Crum-Cianflone; Qian Ren; Lynn E Eberly; Anuradha Ganesan; Amy Weintrob; Vincent Marconi; Robert V Barthel; Brian K Agan
Journal:  J Acquir Immune Defic Syndr       Date:  2010-08       Impact factor: 3.731

5.  Association between the rate of CD4+ T cell decrease and the year of human immunodeficiency virus (HIV) type 1 seroconversion among persons enrolled in the Swiss HIV cohort study.

Authors:  P Vanhems; J Lambert; M Guerra; B Hirschel; R Allard
Journal:  J Infect Dis       Date:  1999-12       Impact factor: 5.226

6.  Ten-year trends in CD4 cell counts at HIV and AIDS diagnosis in a London HIV clinic.

Authors:  P J Easterbrook; L M Yu; E Goetghebeur; F Boag; K McLean; B Gazzard
Journal:  AIDS       Date:  2000-03-31       Impact factor: 4.177

7.  Natural history of human immunodeficiency virus type 1 viremia after seroconversion and proximal to AIDS in a large cohort of homosexual men. Multicenter AIDS Cohort Study.

Authors:  R H Lyles; A Muñoz; T E Yamashita; H Bazmi; R Detels; C R Rinaldo; J B Margolick; J P Phair; J W Mellors
Journal:  J Infect Dis       Date:  2000-03       Impact factor: 5.226

8.  Phylogenetic approach reveals that virus genotype largely determines HIV set-point viral load.

Authors:  Samuel Alizon; Viktor von Wyl; Tanja Stadler; Roger D Kouyos; Sabine Yerly; Bernard Hirschel; Jürg Böni; Cyril Shah; Thomas Klimkait; Hansjakob Furrer; Andri Rauch; Pietro L Vernazza; Enos Bernasconi; Manuel Battegay; Philippe Bürgisser; Amalio Telenti; Huldrych F Günthard; Sebastian Bonhoeffer
Journal:  PLoS Pathog       Date:  2010-09-30       Impact factor: 6.823

9.  Estimating the impact of plasma HIV-1 RNA reductions on heterosexual HIV-1 transmission risk.

Authors:  Jairam R Lingappa; James P Hughes; Richard S Wang; Jared M Baeten; Connie Celum; Glenda E Gray; Wendy S Stevens; Deborah Donnell; Mary S Campbell; Carey Farquhar; M Essex; James I Mullins; Robert W Coombs; Helen Rees; Lawrence Corey; Anna Wald
Journal:  PLoS One       Date:  2010-09-13       Impact factor: 3.240

10.  Brief but efficient: acute HIV infection and the sexual transmission of HIV.

Authors:  Christopher D Pilcher; Hsiao Chuan Tien; Joseph J Eron; Pietro L Vernazza; Szu-Yun Leu; Paul W Stewart; Li-Ean Goh; Myron S Cohen
Journal:  J Infect Dis       Date:  2004-04-28       Impact factor: 5.226

View more
  46 in total

1.  Evolution of the Envelope Glycoprotein of HIV-1 Clade B toward Higher Infectious Properties over the Course of the Epidemic.

Authors:  Laurence Meyer; Francis Barin; Mélanie Bouvin-Pley; Maxime Beretta; Alain Moreau; Emmanuelle Roch; Asma Essat; Cécile Goujard; Marie-Laure Chaix; Nathalie Moiré; Loïc Martin; Martine Braibant
Journal:  J Virol       Date:  2019-03-05       Impact factor: 5.103

2.  Optimizing the Timing of HIV Screening as Part of Routine Medical Care.

Authors:  Matthew R Golden; James P Hughes; Julia C Dombrowski
Journal:  AIDS Patient Care STDS       Date:  2017-01       Impact factor: 5.078

Review 3.  Clinical and evolutionary consequences of HIV adaptation to HLA: implications for vaccine and cure.

Authors:  Santiago Avila-Rios; Jonathan M Carlson; Mina John; Simon Mallal; Zabrina L Brumme
Journal:  Curr Opin HIV AIDS       Date:  2019-05       Impact factor: 4.283

4.  Cumulative impact of host and viral factors on HIV-1 viral-load control during early infection.

Authors:  Ling Yue; Heather A Prentice; Paul Farmer; Wei Song; Dongning He; Shabir Lakhi; Paul Goepfert; Jill Gilmour; Susan Allen; Jianming Tang; Richard A Kaslow; Eric Hunter
Journal:  J Virol       Date:  2012-10-31       Impact factor: 5.103

Review 5.  The impact of host genetic variation on infection with HIV-1.

Authors:  Paul J McLaren; Mary Carrington
Journal:  Nat Immunol       Date:  2015-06       Impact factor: 25.606

6.  Significant reductions in Gag-protease-mediated HIV-1 replication capacity during the course of the epidemic in Japan.

Authors:  Shigeru Nomura; Noriaki Hosoya; Zabrina L Brumme; Mark A Brockman; Tadashi Kikuchi; Michiko Koga; Hitomi Nakamura; Tomohiko Koibuchi; Takeshi Fujii; Jonathan M Carlson; David Heckerman; Ai Kawana-Tachikawa; Aikichi Iwamoto; Toshiyuki Miura
Journal:  J Virol       Date:  2012-11-14       Impact factor: 5.103

Review 7.  HIV transmission biology: translation for HIV prevention.

Authors:  Keshet Ronen; Amit Sharma; Julie Overbaugh
Journal:  AIDS       Date:  2015-11       Impact factor: 4.177

8.  A transmission-virulence evolutionary trade-off explains attenuation of HIV-1 in Uganda.

Authors:  François Blanquart; Mary Kate Grabowski; Joshua Herbeck; Fred Nalugoda; David Serwadda; Michael A Eller; Merlin L Robb; Ronald Gray; Godfrey Kigozi; Oliver Laeyendecker; Katrina A Lythgoe; Gertrude Nakigozi; Thomas C Quinn; Steven J Reynolds; Maria J Wawer; Christophe Fraser
Journal:  Elife       Date:  2016-11-05       Impact factor: 8.140

9.  Impact of HLA-driven HIV adaptation on virulence in populations of high HIV seroprevalence.

Authors:  Rebecca Payne; Maximilian Muenchhoff; Jaclyn Mann; Hannah E Roberts; Philippa Matthews; Emily Adland; Allison Hempenstall; Kuan-Hsiang Huang; Mark Brockman; Zabrina Brumme; Marc Sinclair; Toshiyuki Miura; John Frater; Myron Essex; Roger Shapiro; Bruce D Walker; Thumbi Ndung'u; Angela R McLean; Jonathan M Carlson; Philip J R Goulder
Journal:  Proc Natl Acad Sci U S A       Date:  2014-12-01       Impact factor: 11.205

Review 10.  Virulence and pathogenesis of HIV-1 infection: an evolutionary perspective.

Authors:  Katrina Lythgoe; Sebastian Bonhoeffer; Christophe Fraser; Gabriel E Leventhal; George Shirreff; T Déirdre Hollingsworth; Samuel Alizon
Journal:  Science       Date:  2014-03-21       Impact factor: 47.728

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.